Rottinghaus Scott T.
SEC CIK 1942407 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | SVP, CMO | 23.8K | — | $214.2K | 16 | 2022-08-08 | 2026-08-08 |
Most active insiders at ENTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| 2 | Or Yat Sun | CSO | — | $34.0K |
| 3 | Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| 4 | Luu Brendan | Chief Business Off | — | $19.8K |
| 5 | Trout Harry R. III | See Remarks | — | $13.0K |
| 6 | Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| 7 | Capps Kathleen S. | See Remarks | — | $7,486 |
| 8 | Kowalsky Matthew Paul | CLO | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 09:00 | 2026-08-08 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $13.34 | -1,467 | 23.8K | -6% | -$19.6K | |
| M | 2026-02-13 | 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +6,875 | 23.4K | +41% | $0 |
| 2026-02-13 | 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $14.25 | -3,413 | 25.3K | -12% | -$48.6K | |
| 2025-12-05 | 2025-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | S - Sale | $14.23 | -798 | 21.8K | -4% | -$11.4K | |
| 2025-08-08 | 2025-08-08 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $6.99 | -2,217 | 22.6K | -9% | -$15.5K | |
| 2025-02-14 | 2025-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +9,750 | 27.7K | +54% | $0 | |
| 2025-02-14 | 2025-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $5.59 | -2,861 | 24.8K | -10% | -$16.0K | |
| 2024-12-10 | 2024-12-06 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | S - Sale | $8.06 | -866 | 17.9K | -5% | -$6,980 | |
| M | 2024-08-09 | 2023-08-08+ | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $14.98 | -2,933 | 18.8K | -14% | -$43.9K |
| DM | 2024-07-15 | 2024-07-11+ | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | S - Sale+OE | $15.97 | -11.9K | 21.7K | -35% | -$190.7K |
| D | 2024-07-15 | 2024-07-15 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | M - OptEx | $8.99 | +5,375 | 27.1K | +25% | +$48.3K |
| 2024-02-14 | 2024-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $12.41 | -755 | 28.3K | -3% | -$9,370 | |
| 2024-02-14 | 2024-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +2,576 | 29.0K | +10% | $0 | |
| 2023-12-06 | 2023-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | SVP, CMO | S - Sale | $9.63 | -534 | 26.5K | -2% | -$5,142 | |
| D | 2022-11-28 | 2022-11-23 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +7,000 | 27.0K | +35% | $0 |
| D | 2022-08-11 | 2022-08-08 | ENTA | ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations